Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

A local score approach improves GWAS resolution and detects minor QTL: application to Medicago truncatula quantitative disease resistance to multiple Aphanomyces euteiches isolates.

Bonhomme M, Fariello MI, Navier H, Hajri A, Badis Y, Miteul H, Samac DA, Dumas B, Baranger A, Jacquet C, Pilet-Nayel ML.

Heredity (Edinb). 2019 May 28. doi: 10.1038/s41437-019-0235-x. [Epub ahead of print]

PMID:
31138867
2.

Gestational Trophoblastic Disease at Sultan Qaboos University Hospital: Prevalence, Risk Factors, Histological Features, Sonographic Findings, and Outcomes.

Al Riyami N, Al Riyami M, Al Hajri AT, Al Saidi S, Salman B, Al Kalbani M.

Oman Med J. 2019 May;34(3):200-204. doi: 10.5001/omj.2019.39.

3.

[Laparoscopic cholecystectomy in a patient with situs inversus].

Boufettal R, Erguibi D, Hajri A, Idrissi A, Jai SR, Chehab F.

Pan Afr Med J. 2018 Nov 15;31:183. doi: 10.11604/pamj.2018.31.183.14061. eCollection 2018. French.

4.

Development of an extraction method for anabolic androgenic steroids in dietary supplements and analysis by gas chromatography-mass spectrometry: Application for doping-control.

Dahmani H, Louati K, Hajri A, Bahri S, Safta F.

Steroids. 2018 Oct;138:134-160. doi: 10.1016/j.steroids.2018.08.001. Epub 2018 Aug 15.

PMID:
30118779
5.

Pistacia lentiscus oil attenuates memory dysfunction and decreases levels of biomarkers of oxidative stress induced by lipopolysaccharide in rats.

Ammari M, Othman H, Hajri A, Sakly M, Abdelmelek H.

Brain Res Bull. 2018 Jun;140:140-147. doi: 10.1016/j.brainresbull.2018.04.014. Epub 2018 Apr 30.

PMID:
29715489
6.

Two ancestral genes shaped the Xanthomonas campestris TAL effector gene repertoire.

Denancé N, Szurek B, Doyle EL, Lauber E, Fontaine-Bodin L, Carrère S, Guy E, Hajri A, Cerutti A, Boureau T, Poussier S, Arlat M, Bogdanove AJ, Noël LD.

New Phytol. 2018 Jul;219(1):391-407. doi: 10.1111/nph.15148. Epub 2018 Apr 20.

PMID:
29677397
7.

Reducing patient waiting time and length of stay in an Acute Care Pediatric Emergency Department.

Al-Onazi M, Al Hajri A, Caswell A, Leizl Hugo Villanueva M, Mohammed Z, Esteves V, Vabasa F, Al-Surimi K.

BMJ Qual Improv Rep. 2017 Jun 26;6(1). pii: u212356.w7916. doi: 10.1136/bmjquality.u212356.w7916. eCollection 2017.

8.

Genetic Characterization of 'Candidatus Liberibacter solanacearum' Haplotypes Associated with Apiaceous Crops in France.

Hajri A, Loiseau M, Cousseau-Suhard P, Renaudin I, Gentit P.

Plant Dis. 2017 Aug;101(8):1383-1390. doi: 10.1094/PDIS-11-16-1686-RE. Epub 2017 May 15.

PMID:
30678593
9.

Synthesis and evaluation of analgesic, behavioral effects and chronic toxicity of the new 3,5-diaminopyrazole and its precursor the thiocyanoacetamide.

Ben Ali R, Ben Othman A, Bokri K, Maghraoui S, Hajri A, Ben Akacha A, Dziri C, El May MV.

Biomed Pharmacother. 2017 Feb;86:109-117. doi: 10.1016/j.biopha.2016.11.119. Epub 2016 Dec 9.

PMID:
27951417
10.

The need for lean thinking in the omani health care sector.

Al Farsi Y, Al Abri R, Al Hajri A, Al Balushi S.

Oman Med J. 2014 Jul;29(4):248-9. doi: 10.5001/omj.2014.66. No abstract available.

11.

Readiness factors for lean implementation in healthcare settings--a literature review.

Al-Balushi S, Sohal AS, Singh PJ, Al Hajri A, Al Farsi YM, Al Abri R.

J Health Organ Manag. 2014;28(2):135-53. Review.

PMID:
25065107
12.

High-density genome-wide association mapping implicates an F-box encoding gene in Medicago truncatula resistance to Aphanomyces euteiches.

Bonhomme M, André O, Badis Y, Ronfort J, Burgarella C, Chantret N, Prosperi JM, Briskine R, Mudge J, Debéllé F, Navier H, Miteul H, Hajri A, Baranger A, Tiffin P, Dumas B, Pilet-Nayel ML, Young ND, Jacquet C.

New Phytol. 2014 Mar;201(4):1328-42. doi: 10.1111/nph.12611. Epub 2013 Nov 28.

13.

Oncosuppressive suicide gene virotherapy "PVH1-yCD/5-FC" for pancreatic peritoneal carcinomatosis treatment: NFκB and Akt/PI3K involvement.

Réjiba S, Bigand C, Parmentier C, Masmoudi A, Hajri A.

PLoS One. 2013 Aug 14;8(8):e70594. doi: 10.1371/journal.pone.0070594. eCollection 2013.

14.

Natural genetic variation of Xanthomonas campestris pv. campestris pathogenicity on arabidopsis revealed by association and reverse genetics.

Guy E, Genissel A, Hajri A, Chabannes M, David P, Carrere S, Lautier M, Roux B, Boureau T, Arlat M, Poussier S, Noël LD.

MBio. 2013 Jun 4;4(3):e00538-12. doi: 10.1128/mBio.00538-12. Erratum in: MBio. 2013;4(6):e00978-13.

15.

Evolutionary history of the plant pathogenic bacterium Xanthomonas axonopodis.

Mhedbi-Hajri N, Hajri A, Boureau T, Darrasse A, Durand K, Brin C, Fischer-Le Saux M, Manceau C, Poussier S, Pruvost O, Lemaire C, Jacques MA.

PLoS One. 2013;8(3):e58474. doi: 10.1371/journal.pone.0058474. Epub 2013 Mar 7.

16.

Variations in type III effector repertoires, pathological phenotypes and host range of Xanthomonas citri pv. citri pathotypes.

Escalon A, Javegny S, Vernière C, Noël LD, Vital K, Poussier S, Hajri A, Boureau T, Pruvost O, Arlat M, Gagnevin L.

Mol Plant Pathol. 2013 Jun;14(5):483-96. doi: 10.1111/mpp.12019. Epub 2013 Feb 26.

PMID:
23437976
17.

A multiplex-PCR assay for identification of the quarantine plant pathogen Xanthomonas axonopodis pv. phaseoli.

Boureau T, Kerkoud M, Chhel F, Hunault G, Darrasse A, Brin C, Durand K, Hajri A, Poussier S, Manceau C, Lardeux F, Saubion F, Jacques MA.

J Microbiol Methods. 2013 Jan;92(1):42-50. doi: 10.1016/j.mimet.2012.10.012. Epub 2012 Nov 8.

PMID:
23142341
18.

Choledochal cysts in Omani children: a case series.

Al-Sinani S, Al Naamani K, Lutfi W, Al Hajri A.

Arab J Gastroenterol. 2012 Jun;13(2):89-92. doi: 10.1016/j.ajg.2012.03.005. Epub 2012 Apr 18.

PMID:
22980599
19.

Type three effector gene distribution and sequence analysis provide new insights into the pathogenicity of plant-pathogenic Xanthomonas arboricola.

Hajri A, Pothier JF, Fischer-Le Saux M, Bonneau S, Poussier S, Boureau T, Duffy B, Manceau C.

Appl Environ Microbiol. 2012 Jan;78(2):371-84. doi: 10.1128/AEM.06119-11. Epub 2011 Nov 18.

20.

Multilocus sequence analysis and type III effector repertoire mining provide new insights into the evolutionary history and virulence of Xanthomonas oryzae.

Hajri A, Brin C, Zhao S, David P, Feng JX, Koebnik R, Szurek B, Verdier V, Boureau T, Poussier S.

Mol Plant Pathol. 2012 Apr;13(3):288-302. doi: 10.1111/j.1364-3703.2011.00745.x. Epub 2011 Sep 19.

PMID:
21929565
21.

Synthesis, spectroscopic characterization and X-ray structure of [1,2a]benzimidazol-2-yl amidine.

Hajri A, Smirani W, Abderrahim R.

Spectrochim Acta A Mol Biomol Spectrosc. 2011 Sep;79(5):1856-9. doi: 10.1016/j.saa.2011.05.075. Epub 2011 May 31.

PMID:
21708483
22.

Symbiont diversity and non-random hybridization among indigenous (Ms) and invasive (B) biotypes of Bemisia tabaci.

Thierry M, Becker N, Hajri A, Reynaud B, Lett JM, Delatte H.

Mol Ecol. 2011 May;20(10):2172-87. doi: 10.1111/j.1365-294X.2011.05087.x. Epub 2011 Apr 7.

PMID:
21476990
23.

Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer.

Réjiba S, Reddy LH, Bigand C, Parmentier C, Couvreur P, Hajri A.

Nanomedicine. 2011 Dec;7(6):841-9. doi: 10.1016/j.nano.2011.02.012. Epub 2011 Mar 17.

PMID:
21419876
24.

A "repertoire for repertoire" hypothesis: repertoires of type three effectors are candidate determinants of host specificity in Xanthomonas.

Hajri A, Brin C, Hunault G, Lardeux F, Lemaire C, Manceau C, Boureau T, Poussier S.

PLoS One. 2009 Aug 14;4(8):e6632. doi: 10.1371/journal.pone.0006632. Erratum in: PLoS One. 2009;4(10). doi: 10.1371/annotation/92d243d0-22b2-44da-9618-83b4aa252724.

25.
26.

Improvement of gemcitabine-based therapy of pancreatic carcinoma by means of oncolytic parvovirus H-1PV.

Angelova AL, Aprahamian M, Grekova SP, Hajri A, Leuchs B, Giese NA, Dinsart C, Herrmann A, Balboni G, Rommelaere J, Raykov Z.

Clin Cancer Res. 2009 Jan 15;15(2):511-9. doi: 10.1158/1078-0432.CCR-08-1088.

27.

Telomerase transcriptional targeting of inducible Bax/TRAIL gene therapy improves gemcitabine treatment of pancreatic cancer.

Wack S, Rejiba S, Parmentier C, Aprahamian M, Hajri A.

Mol Ther. 2008 Feb;16(2):252-60. Epub 2007 Nov 6.

28.

K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment.

Réjiba S, Wack S, Aprahamian M, Hajri A.

Cancer Sci. 2007 Jul;98(7):1128-36. Epub 2007 May 8.

29.
30.
31.
32.

Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomes.

Hajri A, Wack S, Lehn P, Vigneron JP, Lehn JM, Marescaux J, Aprahamian M.

Cancer Gene Ther. 2004 Jan;11(1):16-27.

PMID:
14681723
33.

Feasibility, sensitivity, and reliability of laser-induced fluorescence imaging of green fluorescent protein-expressing tumors in vivo.

Wack S, Hajri A, Heisel F, Sowinska M, Berger C, Whelan M, Marescaux J, Aprahamian M.

Mol Ther. 2003 Jun;7(6):765-73.

34.

In vitro and in vivo efficacy of photofrin and pheophorbide a, a bacteriochlorin, in photodynamic therapy of colonic cancer cells.

Hajri A, Wack S, Meyer C, Smith MK, Leberquier C, Kedinger M, Aprahamian M.

Photochem Photobiol. 2002 Feb;75(2):140-8.

PMID:
11883602
35.

Dual effect of laparoscopy on cell-mediated immunity.

Hajri A, Mutter D, Wack S, Bastien C, Gury JF, Marescaux J, Aprahamian M.

Eur Surg Res. 2000;32(5):261-6.

PMID:
11111169
36.

Human pancreatic carcinoma cells are sensitive to photodynamic therapy in vitro and in vivo.

Hajri A, Coffy S, Vallat F, Evrard S, Marescaux J, Aprahamian M.

Br J Surg. 1999 Jul;86(7):899-906.

PMID:
10417562
37.

Increased tumor growth and spread after laparoscopy vs laparotomy: influence of tumor manipulation in a rat model.

Mutter D, Hajri A, Tassetti V, Solis-Caxaj C, Aprahamian M, Marescaux J.

Surg Endosc. 1999 Apr;13(4):365-70.

PMID:
10094749
38.

Effects of cholecystokinin octapeptide on a pancreatic acinar carcinoma in the rat.

Hajri A, Damgé C.

Pharm Res. 1998 Nov;15(11):1767-74.

PMID:
9834001
39.

Role of nitric oxide in pancreatic tumour growth: in vivo and in vitro studies.

Hajri A, Metzger E, Vallat F, Coffy S, Flatter E, Evrard S, Marescaux J, Aprahamian M.

Br J Cancer. 1998 Oct;78(7):841-9.

40.
41.

Inactivation of p53 in normal human cells increases G2/M arrest and sensitivity to DNA-damaging agents.

Céraline J, Deplanque G, Duclos B, Limacher JM, Hajri A, Noel F, Orvain C, Frébourg T, Klein-Soyer C, Bergerat JP.

Int J Cancer. 1998 Jan 30;75(3):432-8.

42.

In vivo laser-induced fluorescence imaging of a rat pancreatic cancer with pheophorbide-a.

Tassetti V, Hajri A, Sowinska M, Evrard S, Heisel F, Cheng LQ, Miehé JA, Marescaux J, Aprahamian M.

Photochem Photobiol. 1997 Jun;65(6):997-1006.

PMID:
9188279
43.

Photodynamic imaging of a rat pancreatic cancer with pheophorbide a.

Keller P, Sowinska M, Tassetti V, Heisel F, Hajri A, Evrard S, Miehe JA, Marescaux J, Aprahamian M.

Photochem Photobiol. 1996 Jun;63(6):860-7.

PMID:
8992507
44.

Expression and characterization of gastrin-releasing peptide receptor in normal and cancerous pancreas.

Hajri A, Koenig M, Balboni G, Damgé C.

Pancreas. 1996 Jan;12(1):25-35.

PMID:
8927617
45.

Experimental pancreatic cancer in the rat treated by photodynamic therapy.

Evrard S, Keller P, Hajri A, Balboni G, Mendoza-Burgos L, Damgé C, Marescaux J, Aprahamian M.

Br J Surg. 1994 Aug;81(8):1185-9.

PMID:
7953356
46.

Inhibition of growth of a transplanted rat pancreatic acinar carcinoma with CCK-8.

Karsenty L, Hajri A, Aprahamian M, Garaud JC, Doffoël M, Damgé C.

Pancreas. 1993 Mar;8(2):204-11.

PMID:
8460096
47.

[Involvement of the eyelids and the lacrymal system in facial burns].

Lasram L, el Matri L, Ouertani A, Triki F, Nefzi M, Hajri A, Essadam H, Braham F.

Tunis Med. 1992 Dec;70(12):575-7. French. No abstract available.

PMID:
1295176
48.

Gastrin-releasing peptide: in vivo and in vitro growth effects on an acinar pancreatic carcinoma.

Hajri A, Balboni G, Koenig M, Garaud JC, Damgé C.

Cancer Res. 1992 Jul 1;52(13):3726-32.

49.
50.

Inhibition of the growth of transplanted rat pancreatic acinar carcinoma with octreotide.

Hajri A, Bruns C, Marbach P, Aprahamian M, Longnecker DS, Damgé C.

Eur J Cancer. 1991;27(10):1247-52.

PMID:
1683556

Supplemental Content

Support Center